BioCentury
ARTICLE | Company News

Delphian Pharmaceuticals Inc., Duquesne University deal

July 30, 2007 7:00 AM UTC

Delphian exercised its option to take a worldwide, exclusive license to the university's cancer compounds. The antimitotic agents that also reverse tumor resistance are in preclinical development. Fin...